UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements

Archives of toxicology, 2018-01, Vol.92 (1), p.181-194

2018

Volltextzugriff (PDF)

Destruxins: Fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities

Biochemical pharmacology, 2013-08, Vol.86 (3), p.361-377

2013

Volltextzugriff (PDF)

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Clinical cancer research, 2018-02, Vol.24 (4), p.794-806

2018

Volltextzugriff (PDF)

30 The fungal-derived cyclohexadepsipeptide Destruxin E exerts multifaceted anticancer and antiangiogenic activities

European journal of cancer (1990), 2014-11, Vol.50, p.16-16

2014

Volltextzugriff (PDF)

966 Rapid Disturbance of the Intracellular Redox Balance Predicts Sensitivity to the Preclinical Anticancer Ruthenium Compound KP1339

European journal of cancer (1990), 2012-07, Vol.48, p.S232-S232

2012

Volltextzugriff (PDF)

344P Tumor organoids from multifocal metastatic colorectal cancers for personalized oncology

Annals of oncology, 2022-09, Vol.33, p.S694

2022

Volltextzugriff (PDF)

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

European journal of cancer (1990), 2013-10, Vol.49 (15), p.3366-3375

2013

Volltextzugriff (PDF)

Ecthyma gangrenosum in a patient with acute leukemia

Medicinski arhiv, 2010, Vol.64 (6), p.373

2010

Volltextzugriff (PDF)

Combination therapies with HSP90 inhibitors against colorectal cancer

Biochimica et biophysica acta. Reviews on cancer, 2019-04, Vol.1871 (2), p.240-247

2019

Volltextzugriff (PDF)

The COVID Surgery Service (CSS) within the Salzburg COVID‐Emergency Plan (SCEP)

British journal of surgery, 2020-07, Vol.107 (8), p.e244-e244

2020

Volltextzugriff (PDF)

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis

Cancer letters, 2017-09, Vol.404, p.79-88

2017

Volltextzugriff (PDF)

Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars

Biochimica et biophysica acta. Reviews on cancer, 2022-01, Vol.1877 (1), p.188682-188682, Article 188682

2022

Volltextzugriff (PDF)

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo

Cancer letters, 2023-07, Vol.565, p.216237-216237, Article 216237

2023

Volltextzugriff (PDF)

Natural Radioactivity and the Evaluation of Related Radiological Risks in Concrete Used in Prizren District, Kosovo

Atom Indonesia, 2021-12, Vol.47 (3), p.227-232

2021

Volltextzugriff (PDF)

Pharmacy students' knowledge and attitudes about antibiotics in Kosovo

Pharmacy practice, 2016, Vol.14 (1), p.715-715

2016

Volltextzugriff (PDF)

SLC4A10 mutation causes a neurological disorder associated with impaired GABAergic transmission

Brain (London, England : 1878), 2023-11, Vol.146 (11), p.4547-4561

2023

Volltextzugriff (PDF)

Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity

RSC advances, 2016, Vol.6 (61), p.55848-55859

2016

Volltextzugriff (PDF)

Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation

Dalton transactions : an international journal of inorganic chemistry, 2014-01, Vol.43 (3), p.196-114

2014

Volltextzugriff (PDF)

Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes

Macromolecular bioscience, 2016-08, Vol.16 (8), p.1239-1249

2016

Volltextzugriff (PDF)

Abstract 2573: Investigation of factors involved in the hypersensitivity to KP1339-treatment

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2573-2573

2015

Volltextzugriff (PDF)

Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4397-4397

2015

Volltextzugriff (PDF)

Abstract IA009: Tumor organoids of multi-metastatic colorectal cancer: From research tools to treatment decision tools

Cancer research (Chicago, Ill.), 2022-12, Vol.82 (23_Supplement_1), p.IA009-IA009

2022

Volltextzugriff (PDF)

Tumour Organoids from Multifocal Metastatic Colorectal Cancers for Personalised Oncology

European medical journal. Oncology, 2022-10, p.30-31

2022

Volltextzugriff (PDF)

Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells

Medical microbiology and immunology, 2014-08, Vol.203 (4), p.217-229

2014

Volltextzugriff (PDF)

Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3541-3541

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaAbsorption

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(32)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(12)
Humans
(11)
Oncology
(6)
Animals
(4)
Antineoplastic Agents - Pharmacology
(4)
Cell Line, Tumor
(4)
Biochemistry & Molecular Biology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Organometallic Compounds - Pharmacology
(3)
Physical Sciences
(3)
Technology
(3)
Tumors
(3)
Urology
(3)
Antineoplastic Agents - Chemistry
(2)
Antitumor Activity
(2)
Apoptosis
(2)
Apoptosis - Drug Effects
(2)
Biomedical And Life Sciences
(2)
Biomedicine
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements

Destruxins: Fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

30 The fungal-derived cyclohexadepsipeptide Destruxin E exerts multifaceted anticancer and antiangiogenic activities

966 Rapid Disturbance of the Intracellular Redox Balance Predicts Sensitivity to the Preclinical Anticancer Ruthenium Compound KP1339

344P Tumor organoids from multifocal metastatic colorectal cancers for personalized oncology

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

Ecthyma gangrenosum in a patient with acute leukemia

Combination therapies with HSP90 inhibitors against colorectal cancer

The COVID Surgery Service (CSS) within the Salzburg COVID‐Emergency Plan (SCEP)

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis

Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo

Natural Radioactivity and the Evaluation of Related Radiological Risks in Concrete Used in Prizren District, Kosovo

Pharmacy students' knowledge and attitudes about antibiotics in Kosovo

SLC4A10 mutation causes a neurological disorder associated with impaired GABAergic transmission

Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity

Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation

Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes

Abstract 2573: Investigation of factors involved in the hypersensitivity to KP1339-treatment

Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design

Abstract IA009: Tumor organoids of multi-metastatic colorectal cancer: From research tools to treatment decision tools

Tumour Organoids from Multifocal Metastatic Colorectal Cancers for Personalised Oncology

Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells

Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma

Aktive Filter

Suchergebnisse filtern